Interim Results
Swallowfield PLC
24 February 2005
Swallowfield plc
Interim results for the 28 weeks ended 8 January 2005
Chairman's Statement
Results
I am pleased to report, that for the first six months of the financial year,
turnover increased by 5% from £23.4m to £24.7m and profit before tax increased
by 68% to £0.6m. This is a good result when measured against the set of
unfavourable background conditions to which we are subject, and that I described
in my last report. The personal care market has remained weak and customer
imposed price pressure has continued. In addition, we have witnessed a limited
resurgence of raw material price inflation driven by higher costs of
petrochemical derivatives and base metals such as aluminium and tinplate. Our
strategy to address these factors has been effective to date.
Savings from last year's restructuring programme are broadly on track, and we
have been able to re-invest approximately half of these savings to begin to
build our operation in the Peoples' Republic of China. This new operation is
growing steadily - we have had our first finished product manufactured by local
sub-contractors and have placed purchase orders for newly tooled components.
Turnover in the Cosmetics business increased by 6% from £6.3m to £6.7m and,
encouragingly, this division made an operating profit of £0.1m following an
operating loss of £0.3m over the same period last year. This turnaround has been
achieved through a combination of improved sales performance from recently
launched product ranges and overhead savings made during the last two years.
Turnover in the Aerosols division increased 5% from £17.2m to £18.0m, and
operating profit decreased by 10% to £0.8m - the increased pricing pressure on
toiletry gift packs has been particularly noticeable during the last 6 months.
We are taking positive steps to value engineer new products and increase the
sourcing of components from the Far East.
Cash and Net Debt
The Group has generated operating cash flow of £5.1m since the last year-end as
a result of which net debt has been reduced by £3.6m to £5.2m. Much of this
improvement comes from the completion of a single customer contract with
extended payment terms described in my last report, together with other seasonal
factors. Gearing stands at 42% compared with 73% at the end of the last
financial year and 44% at the interim stage last year.
During the last six months we have prudently increased our expenditure on fixed
assets totalling £0.9m, with particular emphasis being placed on good
manufacturing practice. We have recently completed the installation of a new
microbiological testing facility and a new water treatment plant.
Strategy Update
We continue to refine our strategy in the light of new information and changes
within our market place. We are also exploring potential acquisitions that could
either provide extensions to our product capabilities and/or create synergistic
benefits with our current operations.
At the same time, we are examining opportunities to organically grow our
business. Following efforts made over the last several months, we have very
recently been awarded a significant outsourcing contract by a well-known brand.
Under this contract, Swallowfield will manufacture the majority of this
customer's aerosol requirement for an initial term of three years. We are clear
that overall service levels, including new product development, are paramount to
the success of this new business and believe similar opportunities exist with
other potential customers.
In the strategy update presented last year, we stated that we have set ourselves
a long-term target to achieve a return on shareholders equity of 12% by 30 June
2006, and 15% by 30 June 2009. Excluding exceptional costs, return on equity for
the 12 months to 8 January 2005 was 10%.
Outlook
The economic background is not expected to improve over the coming 6 months.
Indeed, following the recently published December 2004 retail sales figures, our
expectation and planning is that consumer spending could yet deteriorate
further. This background and continuing price pressures are likely to make the
second half of the financial year slightly tougher than originally anticipated.
However, raw material and production savings from our Chinese operation, and
sales from the new business referred to above, will start to come through
towards the end of the fourth quarter and should have a positive impact going
forward.
The key to our future success remains our ability to innovate and create
products that consumers wish to buy, at the same time we will not let-up on our
relentless pursuit of improving our cost base and increasing operating
efficiencies.
Dividend
The Board has maintained the dividend policy explained in the last annual report
and accounts. This policy recognises the need, in the short term, for us to
rebuild the level of dividend cover and increase the strength of the Group's
balance sheet. In the medium term, our aim of pursuing a progressive dividend
policy remains. Accordingly, the Board has declared an interim dividend of 2.8p
per share, which is unchanged from that declared at the same time last year. The
dividend will be paid on the 26 May 2005 to shareholders on the register on 13
May 2005, and the shares will go ex-dividend on 11 May 2005.
J S Espey, Chairman
24 February 2005
Group Profit and Loss Account
for the 28 weeks ended 8 January 2005
28 weeks 28 weeks 12 months
ended ended ended
8 Jan 2005 10 Jan 2004 30 June 2004
(unaudited) (unaudited)
Notes £'000 £'000 £'000
Turnover 1 24,677 23,433 48,763
Operating profit 1 860 588 1,584
Interest payable (240) (218) (419)
Profit on ordinary activities before taxation 620 370 1,165
Tax on profit on ordinary activities (189) (107) (349)
Profit attributable to shareholders 431 263 816
Dividends (316) (316) (541)
Retained profit/(loss) 115 (53) 275
Dividend per ordinary share 3 2.8p 2.8p 4.8p
Earnings per ordinary share
- Basic 4 3.8p 2.3p 7.2p
- Diluted 4 3.8p 2.3p 7.2p
Group Balance Sheet
as at 8 January 2005
As at As at As at
8 Jan 2005 10 Jan 2004 30 June 2004
(unaudited) (unaudited)
£'000 £'000 £'000
Tangible fixed assets 12,501 12,682 12,382
Stocks 7,705 7,570 7,982
Debtors 7,130 5,632 14,219
Cash at bank and in hand 69 483 94
14,904 13,685 22,295
Creditors: amounts falling due within one year (9,765) (8,474) (14,998)
Net current assets 5,139 5,211 7,297
Creditors: amounts falling due after more than one (4,514) (5,313) (6,668)
year
Provisions for liabilities and charges (947) (844) (947)
12,179 11,736 12,064
Share capital 563 563 563
Share premium 3,796 3,796 3,796
Reserves 7,820 7,377 7,705
Equity shareholders' funds 12,179 11,736 12,064
Group Statement of Cash Flows
for the 28 weeks ended 8 January 2005
28 weeks 28 weeks 12 months
ended ended ended
8 Jan 2005 10 Jan 2004 30 June 2004
(unaudited) (unaudited)
£'000 £'000 £'000
Net cash inflow from operating activities (note I) 5,101 4,512 1,897
Returns on investments and servicing of finance (240) (218) (419)
Corporation tax paid (162) (92) (190)
Capital expenditure:
Purchase of tangible fixed assets (860) (368) (696)
Sale of tangible fixed assets 5 40 2
Equity dividends paid (225) (225) (541)
Net cash inflow before financing 3,619 3,649 53
Financing:
(Decrease) in long and short-term loans (2,003) (1,532) (32)
Capital element of finance lease rentals (181) (200) (351)
(2,184) (1,732) (383)
Increase/(decrease) in cash 1,435 1,917 (330)
Notes to the Statement of Cash Flows
28 weeks 28 weeks 12 months
ended ended ended
8 Jan 2005 10 Jan 2004 30 June 2004
(unaudited) (unaudited)
£'000 £'000 £'000
I. Reconciliation of operating profit to net cash
inflow from operating activities
Operating profit 860 588 1,584
Depreciation 741 822 1,488
(Profit) on disposal of fixed assets (5) (2) (2)
Decrease/(increase) in stocks 277 46 (366)
Decrease/(increase) in debtors 7,089 3,638 (4,952)
(Decrease)/increase in creditors (3,861) (580) 4,145
Net cash inflow from operating activities 5,101 4,512 1,897
II. Analysis of net debt
Net cash at bank and in hand 69 483 94
Overdraft (398) - (1,858)
Short-term loans - (3) (3)
Long-term loans (4,000) (4,500) (6,000)
Finance leases (833) (1,165) (1,014)
(5,162) (5,185) (8,781)
III. Reconciliation of net cash flow to movement in net debt
Net debt at start of the period (8,781) (8,834) (8,834)
Increase/(decrease) in cash 1,435 1,917 (330)
Decrease in borrowings and finance leases 2,184 1,732 383
Net debt at end of the period (5,162) (5,185) (8,781)
Notes to the Financial Information
1. Turnover and segmental analysis
28 weeks ended 28 weeks ended 12 months ended
8 Jan 2005 10 Jan 2004 30 June 2004
Class of business Operating Operating Operating
Profit Profit Profit
Turnover Turnover Turnover
£'000 £'000 £'000 £'000 £'000 £'000
(unaudited) (unaudited) (unaudited) (unaudited)
Aerosol products 18,018 762 17,158 845 36,520 1,986
Cosmetic products 6,659 98 6,275 (257) 12,243 (6)
24,677 860 23,433 588 48,763 1,980
Operating profit before
exceptional costs
Exceptional costs - - - - - (396)
Operating profit 24,677 860 23,433 588 48,763 1,584
2. The results for the twenty-eight weeks ended 8 January 2005 and the summary
balance sheet on that date are unaudited. The results for the 12 month period
ended 30 June 2004 do not constitute full accounts within the meaning of section
240 of the Companies Act 1985. Full accounts for that period together with an
unqualified audit report thereon have been filed with the Registrar of
Companies.
3. The dividend comprises an ordinary dividend of 2.8p (2004: 2.8p) per
ordinary share payable on 26 May 2005 to shareholders on the register on 13 May
2005.
4. The calculation of basic earnings per share is based on 11,256,416 (2004:
11,256,416) ordinary shares of 5.0p each, being the weighted average number of
ordinary shares in issue during the period, and the profit on ordinary
activities after taxation of £431,000 (2004: £263,000).
The diluted earnings per share is based on the profit for the period of £431,000
(2004: £263,000) and on the weighted average number of shares in issue for the
period, adjusted for shares held under unexercised options. The adjusted number
of shares for the period was 11,268,118 (2004: 11,266,316) ordinary shares which
include 11,702 (2004: 9,900) dilutive potential ordinary shares from executive
share options.
5. The Interim Report will be sent to shareholders and is available to members
of the public at the Company's Registered Office at Swallowfield House, Station
Road, Wellington, Somerset, TA21 8NL.
This information is provided by RNS
The company news service from the London Stock Exchange